Drugs Made In America Acquisition DMAAU

NASDAQ DMAAU
$10.79 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM EDT
Financial Ratios
Add ratio to table…

About

Drugs Made In America Acquisition Corp is a blank check company incorporated in the Cayman Islands as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company has neither engaged in any operations nor generated any revenue to date. Based on its business activities, it is considered a shell company under the…

Read more ↓
Sector: Financial Services Sector rationale The company is a blank check company (SPAC) that exists solely to raise capital through an IPO and private placements to fund a future acquisition. Its only current activity is the management of a trust account for investment purposes, which falls under the financial services model of capital raising and asset management. Industry: Alternative Asset Managers Financial Services Primary The company is a blank check company (SPAC) whose sole purpose is to raise capital to effect a merger or asset acquisition. This activity of pooling capital to acquire and invest in private businesses aligns most closely with the strategies of alternative asset managers and private equity firms described in F-11. Classified using BQ-MICS CIK: 0002028614